• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ligand Pharmaceuticals Incorporated - Common Stock (NQ:LGND)

    211.16 -21.39 (-9.20%)
    Streaming Delayed Price Updated: 2:25 PM EDT, May 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 367,180
    Open 205.00
    Bid (Size) 210.01 (100)
    Ask (Size) 212.31 (200)
    Prev. Close 232.55
    Today's Range 200.01 - 225.63
    52wk Range 98.89 - 247.38
    Shares Outstanding 16,676,532
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Ligand Pharmaceuticals (NASDAQ:LGND) Shares Fall on Q1 Revenue and EPS Miss ↗
    Via Chartmill
    News headline image
    Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +11.1%
    +11.1%
    1 Month
    +3.7%
    +3.7%
    3 Month
    +6.5%
    +6.5%
    6 Month
    +10.9%
    +10.9%
    1 Year
    +104.4%
    +104.4%

    More News

    Read More
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Villere St Denis Liquidates $18 Million Euronet Worldwide Stake, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Ligand Pharmaceuticals (NASDAQ:LGND) Passes Minervini Trend Template and Growth Screen ↗
    Via Chartmill
    News headline image
    Villere St Denis Dumps 134,000 Tidewater (TDW) Shares Worth $9.3 Million ↗
    Via The Motley Fool
    Topics Energy Regulatory Compliance
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
    From XOMA Royalty Corporation
    Via GlobeNewswire
    Ligand Pharmaceuticals (NASDAQ:LGND) Beats Q4 Estimates and Reaffirms 2026 Guidance ↗
    Via Chartmill
    News headline image
    CLO Sells LGND 5,000 Shares for $1.0 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Rice Hall James Buys QuidelOrtho Stock ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Rice Hall James Buys Stride Stock ↗
    Via The Motley Fool
    News headline image
    Ligand Pharma (LGND) Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    The Great Rotation: Small-Caps Break the Mega-Cap Monopoly in Early 2026
    Via MarketMinute
    Topics Artificial Intelligence Earnings Economy
    News headline image
    This $38.8 Million Vicor Bet Is Getting Bigger Amid a 200% Stock Surge ↗
    Via The Motley Fool
    News headline image
    Sportradar Stock Down 26%, but One Fund Just Disclosed a New $12.6 Million Stake ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    What Investors Should Know as One Fund Sells $11 Million of Cavco Industries Stock ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Fund Sells $23 Million in Globalstar as Stock Surges 170% in One Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Chime Is Down 27% From Its IPO Price, Yet Posting 29% Revenue Growth: Why This New $15 Million Bet Stands Out ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Solaris Stock Is Up 100% This Past Year, and One Fund Is Betting $29 Million on More Growth ↗
    Via The Motley Fool
    Topics Energy
    News headline image
    Stock Up 40% in a Year, $706 Million in Quarterly Sales: Why Boot Barn’s Trimmed Stake Deserves a Look ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year ↗
    Via Investor's Business Daily
    News headline image
    This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Small-Cap Fund Bought $11 Million in Cellebrite Stock Last Quarter ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Ligand Pharmaceuticals Incorporated - Common Stock publicly traded?
    Yes, Ligand Pharmaceuticals Incorporated - Common Stock is publicly traded.
    What exchange does Ligand Pharmaceuticals Incorporated - Common Stock trade on?
    Ligand Pharmaceuticals Incorporated - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock?
    The ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock is LGND on the Nasdaq Stock Market
    What is the current price of Ligand Pharmaceuticals Incorporated - Common Stock?
    The current price of Ligand Pharmaceuticals Incorporated - Common Stock is 211.16
    When was Ligand Pharmaceuticals Incorporated - Common Stock last traded?
    The last trade of Ligand Pharmaceuticals Incorporated - Common Stock was at 05/07/26 02:25 PM ET
    What is the market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock?
    The market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock is 3.52B
    How many shares of Ligand Pharmaceuticals Incorporated - Common Stock are outstanding?
    Ligand Pharmaceuticals Incorporated - Common Stock has 4B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.